Cargando…

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) has anti-apoptotic functions, which may protect TIMP-1 positive cancer cells from the effects of chemotherapy such as docetaxel and gemcitabine. The purpose of the present study was to evaluate TIMP-1 immunoreactivity as a prognostic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jørgensen, Charlotte Levin Tykjær, Bjerre, Christina, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Bartels, Annette, Brünner, Nils, Nielsen, Dorte L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091674/ https://www.ncbi.nlm.nih.gov/pubmed/24884504 http://dx.doi.org/10.1186/1471-2407-14-360

Ejemplares similares

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine
por: Jørgensen, Charlotte LT, et al.
Publicado: (2013)

Danish Breast Cancer Cooperative Group
por: Christiansen, Peer, et al.
Publicado: (2016)

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
por: Kümler, Iben, et al.
Publicado: (2019)

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
por: Buhl, Anna Sofie Kappel, et al.
Publicado: (2018)

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
por: Munro, Alison F, et al.
Publicado: (2013)

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
por: Cold, Søren, et al.
Publicado: (2022)

The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study
por: Bens, Annet, et al.
Publicado: (2020)

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
por: Steffensen, Ane Y., et al.
Publicado: (2010)

Breast cancer survival and season of surgery: an ecological open cohort study
por: Teilum, Dorthe, et al.
Publicado: (2012)

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
por: Kümler, Iben, et al.
Publicado: (2016)

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
por: Stovgaard, Elisabeth S, et al.
Publicado: (2021)

High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients
por: Nielsen, Kåre, et al.
Publicado: (2023)

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients
por: Jensen, Maj-Britt, et al.
Publicado: (2020)

Completeness of colon and rectal cancer staging in the Danish Cancer Registry, 2004–2009
por: Ostenfeld, Eva Bjerre, et al.
Publicado: (2012)

Whole genome sequencing of breast cancer
por: Rossing, Maria, et al.
Publicado: (2019)

Types of treatment collaboration between conventional and alternative practitioners—results from a research project at a Danish MS hospital
por: Skovgaard, Lasse, et al.
Publicado: (2010)

Comorbidity and survival of Danish patients with colon and rectal cancer from 2000–2011: a population-based cohort study
por: Ostenfeld, Eva Bjerre, et al.
Publicado: (2013)

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2020)

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
por: Larsson, Anna-Maria, et al.
Publicado: (2020)

The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells
por: Høeberg, Mikkel, et al.
Publicado: (2023)

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
por: Kümler, Iben, et al.
Publicado: (2015)

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
por: Cold, S, et al.
Publicado: (2005)

Mutations of the BRCA1 and BRCA2 Genes in Danish Patients Diagnosed at Young Age with Multi-Centric or Bilateral Breast Cancer
por: Bergthorsson, J. T., et al.
Publicado: (1999)

A catalog of curated breast cancer genes
por: Bose, Muthiah, et al.
Publicado: (2021)

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2021)

MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
por: Jinga, D C, et al.
Publicado: (2006)

Timp3 Deficient Mice Show Resistance to Developing Breast Cancer
por: Jackson, Hartland W., et al.
Publicado: (2015)

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
por: Larsson, Anna-Maria, et al.
Publicado: (2018)

Active smoking and risk of breast cancer in a Danish nurse cohort study
por: Andersen, Zorana Jovanovic, et al.
Publicado: (2017)

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
por: Cronin-Fenton, D P, et al.
Publicado: (2007)

Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections: a Danish cohort study
por: Ostenfeld, Eva Bjerre, et al.
Publicado: (2015)

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
por: Skriver, Signe Korsgaard, et al.
Publicado: (2020)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2021)

Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer
por: Chen, Wen-Quan, et al.
Publicado: (2021)

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study
por: Thorsen, Stine B, et al.
Publicado: (2013)

A Nurse-Led Telephone Session and Quality of Life after Radiotherapy Among Women with Breast Cancer: A Randomized Trial
por: Høyer, Birgit Bjerre, et al.
Publicado: (2011)

Statin use and risk of contralateral breast cancer: a nationwide cohort study
por: Langballe, Rikke, et al.
Publicado: (2018)

Correction: Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2023)

Heavy-Load Lifting: Acute Response in Breast Cancer Survivors at Risk for Lymphedema
por: BLOOMQUIST, KIRA, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g0u7furvuf27hgplfascvjtd8t